Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2026-04-21 @ 9:38 AM
Study NCT ID:
NCT01645293
Status:
UNKNOWN
Last Update Posted:
2012-07-20
First Post:
2012-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Multicentre Phase I Trial of Engineered T Cells for Patients With Relapsed or Refractory Primary Cutaneous CD30+ Large T Cell Lymphoma or Transformed CD30+ Mycosis Fungoides
Sponsor:
University of Cologne
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Uni-Koeln-1065
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None